Adamis Pharmaceuticals (ADMP) Q1 2023 Earnings

15MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-0.06
-0.05
-0.03
-0.02

Details

Expected EPS
N/A
Actual EPS
-0.06
Surprise EPS
-0.06
Surprise Percent
+∞%

Description

Adamis Pharmaceuticals (ADMP) has reported earnings of -0.06 per share for Q1 2023.

0 Comments

Share your thoughts